Capital International Investors Purchases 9,346,295 Shares of agilon health, inc. (NYSE:AGL)

Capital International Investors increased its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 72.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 22,331,873 shares of the company's stock after acquiring an additional 9,346,295 shares during the period. Capital International Investors owned approximately 5.42% of agilon health worth $42,431,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Oak Thistle LLC purchased a new position in shares of agilon health during the fourth quarter worth about $25,000. Ieq Capital LLC bought a new stake in agilon health during the fourth quarter valued at approximately $26,000. Signaturefd LLC grew its stake in agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after buying an additional 8,467 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of agilon health in the 4th quarter worth $33,000. Finally, Cerity Partners LLC purchased a new stake in shares of agilon health during the 4th quarter valued at $34,000.

agilon health Trading Down 2.6 %

Shares of AGL traded down $0.10 during mid-day trading on Thursday, hitting $3.82. 4,866,898 shares of the company's stock traded hands, compared to its average volume of 4,827,403. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $1.57 billion, a P/E ratio of -4.06 and a beta of 0.38. The business's 50-day moving average price is $4.17 and its 200-day moving average price is $3.13. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73.

Wall Street Analyst Weigh In

A number of research analysts recently commented on AGL shares. Needham & Company LLC reissued a "hold" rating on shares of agilon health in a research note on Friday, March 21st. TD Cowen increased their price objective on agilon health from $3.50 to $6.00 and gave the company a "hold" rating in a research report on Tuesday, April 15th. Robert W. Baird decreased their price objective on agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Royal Bank of Canada upped their target price on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Finally, Cowen reissued a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $4.60.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.